Protective role of systemic furin in immune response-induced arthritis

Arthritis and Rheumatism

Volumn 64, Issue 9, 2012, Pages 2878-2886

  Lin, Hilène ^a   Ah Kioon, Marie Dominique ^a   Lalou, Claude ^b   Larghero, Jerome ^a   Launay, Jean Marie ^c   Khatib, Abdel Majid ^b   Cohen Solal, Martine ^a  

^a INSERM   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c HÔPITAL LARIBOISIÈRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 PDX; ANTIRHEUMATIC AGENT; FURIN; GELATINASE A; GELATINASE B; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 4; MATRIX METALLOPROTEINASE 14; TRANSCRIPTION FACTOR PDX 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CASE REPORT; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; JOINT DESTRUCTION; MOUSE; NONHUMAN; OSTEOLYSIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PROCESSING; REGULATORY T LYMPHOCYTE; RHEUMATOID ARTHRITIS; SPLEEN; TH1 TH2 BALANCE;

ALPHA 1-ANTITRYPSIN; ANIMALS; ARTHRITIS, EXPERIMENTAL; CYTOKINES; FURIN; HUMANS; JOINTS; MALE; MICE; MICE, INBRED DBA; RHEUMATIC FEVER; SYNOVIAL MEMBRANE;

EID: 84865627221     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.34523     Document Type: Article

References (36)

1. Schulze-Koops H, Kalden JR,. The balance of Th1/Th2 cytokines in rheumatoid arthritis. Best Pract Res Clin Rheumatol 2001; 15: 677-91.
2. Schett G,. Immune cells and mediators of inflammatory arthritis [review]. Autoimmunity 2008; 41: 224-9.
3. Kraan MC, Versendaal H, Jonker M, Bresnihan B, Post WJ, 't Hart BA, et al. Asymptomatic synovitis precedes clinically manifest arthritis. Arthritis Rheum 1998; 41: 1481-8.
4. Creemers JW, Khatib AM,. Knock-out mouse models of proprotein convertases: unique functions or redundancy? Front Biosci 2008; 13: 4960-71.
5. Kang T, Nagase H, Pei D,. Activation of membrane-type matrix metalloproteinase 3 zymogen by the proprotein convertase furin in the trans-Golgi network. Cancer Res 2002; 62: 675-81.
6. Roghi C, Jones L, Gratian M, English WR, Murphy G,. Golgi reassembly stacking protein 55 interacts with membrane-type (MT) 1-matrix metalloprotease (MMP) and furin and plays a role in the activation of the MT1-MMP zymogen. FEBS J 2010; 277: 3158-75.
7. Koo BH, Apte SS,. Cell-surface processing of the metalloprotease pro-ADAMTS9 is influenced by the chaperone GRP94/gp96. J Biol Chem 2010; 285: 197-205.
8. Longpre JM, McCulloch DR, Koo BH, Alexander JP, Apte SS, Leduc R,. Characterization of proADAMTS5 processing by proprotein convertases. Int J Biochem Cell Biol 2009; 41: 1116-26.
9. Liu J, Afroza H, Rader DJ, Jin W,. Angiopoietin-like protein 3 inhibits lipoprotein lipase activity through enhancing its cleavage by proprotein convertases. J Biol Chem 2010; 285: 27561-70.
10. Cao J, Rehemtulla A, Pavlaki M, Kozarekar P, Chiarelli C,. Furin directly cleaves proMMP-2 in the trans-Golgi network resulting in a nonfunctioning proteinase. J Biol Chem 2005; 280: 10974-80.
11. Gordon VM, Klimpel KR, Arora N, Henderson MA, Leppla SH,. Proteolytic activation of bacterial toxins by eukaryotic cells is performed by furin and by additional cellular proteases. Infect Immun 1995; 63: 82-7.
12. Moulard M, Hallenberger S, Garten W, Klenk HD,. Processing and routage of HIV glycoproteins by furin to the cell surface. Virus Res 1999; 60: 55-65.
13. Milner JM, Rowan AD, Elliott SF, Cawston TE,. Inhibition of furin-like enzymes blocks interleukin-1α/oncostatin M-stimulated cartilage degradation. Arthritis Rheum 2003; 48: 1057-66.
14. Arner EC,. Aggrecanase-mediated cartilage degradation. Curr Opin Pharmacol 2002; 2: 322-9.
15. Pesu M, Watford WT, Wei L, Xu L, Fuss I, Strober W, et al. T-cell-expressed proprotein convertase furin is essential for maintenance of peripheral immune tolerance. Nature 2008; 455: 246-50.
16. Saidenberg-Kermanac'h N, Corrado A, Lemeiter D, deVernejoul MC, Boissier MC, Cohen-Solal ME,. TNF-α antibodies and osteoprotegerin decrease systemic bone loss associated with inflammation through distinct mechanisms in collagen-induced arthritis. Bone 2004; 35: 1200-7.
17. Lalou C, Scamuffa N, Mourah S, Plassa F, Podgorniak MP, Soufir N, et al. Inhibition of the proprotein convertases represses the invasiveness of human primary melanoma cells with altered p53, CDKN2A and N-Ras genes. PLoS One 2010; 5: e9992.
18. Ra HJ, Parks WC,. Control of matrix metalloproteinase catalytic activity. Matrix Biol 2007; 26: 587-96.
19. Schett G, Stach C, Zwerina J, Voll R, Manger B,. How antirheumatic drugs protect joints from damage in rheumatoid arthritis [review]. Arthritis Rheum 2008; 58: 2936-48.
20. Tang Q, Bluestone JA,. Regulatory T-cell physiology and application to treat autoimmunity. Immunol Rev 2006; 212: 217-37.
21. + regulatory T cells in the human immune system. Nat Rev Immunol 2010; 10: 490-500.
22. Notley CA, Ehrenstein MR,. The yin and yang of regulatory T cells and inflammation in RA. Nat Rev Rheumatol 2010; 6: 572-7.
23. Sakaguchi S, Yamaguchi T, Nomura T, Ono M,. Regulatory T cells and immune tolerance. Cell 2008; 133: 775-87.
24. Esensten JH, Wofsy D, Bluestone JA,. Regulatory T cells as therapeutic targets in rheumatoid arthritis. Nat Rev Rheumatol 2009; 5: 560-5.
25. Zou W,. Regulatory T cells, tumour immunity and immunotherapy. Nat Rev Immunol 2006; 6: 295-307.
26. Annunziato F, Cosmi L, Liotta F, Maggi E, Romagnani S,. Type 17 T helper cells: origins, features and possible roles in rheumatic disease. Nat Rev Rheumatol 2009; 5: 325-31.
27. Scamuffa N, Siegfried G, Bontemps Y, Ma L, Basak A, Cherel G, et al. Selective inhibition of proprotein convertases represses the metastatic potential of human colorectal tumor cells. J Clin Invest 2008; 118: 352-63.
28. Siegfried G, Basak A, Prichett-Pejic W, Scamuffa N, Ma L, Benjannet S, et al. Regulation of the stepwise proteolytic cleavage and secretion of PDGF-B by the proprotein convertases. Oncogene 2005; 24: 6925-35.
29. Siegfried G, Basak A, Cromlish JA, Benjannet S, Marcinkiewicz J, Chretien M, et al. The secretory proprotein convertases furin, PC5, and PC7 activate VEGF-C to induce tumorigenesis. J Clin Invest 2003; 111: 1723-32.
30. Siegfried G, Khatib AM, Benjannet S, Chretien M, Seidah NG,. The proteolytic processing of pro-platelet-derived growth factor-A at RRKR(86) by members of the proprotein convertase family is functionally correlated to platelet-derived growth factor-A-induced functions and tumorigenicity. Cancer Res 2003; 63: 1458-63.
31. Scamuffa N, Calvo F, Chretien M, Seidah NG, Khatib AM,. Proprotein convertases: lessons from knockouts. FASEB J 2006; 20: 1954-63.
32. Khatib AM, Auguste P, Fallavollita L, Wang N, Samani A, Kontogiannea M, et al. Characterization of the host proinflammatory response to tumor cells during the initial stages of liver metastasis. Am J Pathol 2005; 167: 749-59.
33. Wang P, Tortorella M, England K, Malfait AM, Thomas G, Arner EC, et al. Proprotein convertase furin interacts with and cleaves pro-ADAMTS4 (Aggrecanase-1) in the trans-Golgi network. J Biol Chem 2004; 279: 15434-40.
34. Moldovan F, Pelletier JP, Mineau F, Dupuis M, Cloutier JM, Martel-Pelletier J,. Modulation of collagenase 3 in human osteoarthritic cartilage by activation of extracellular transforming growth factor β: role of furin convertase. Arthritis Rheum 2000; 43: 2100-9.
35. Wahl SM, Chen W,. Transforming growth factor-β-induced regulatory T cells referee inflammatory and autoimmune diseases. Arthritis Res Ther 2005; 7: 62-8.
36. Jung S, Park YK, Shin JH, Lee H, Kim SY, Lee GR, et al. The requirement of natural killer T-cells in tolerogenic APCs-mediated suppression of collagen-induced arthritis. Exp Mol Med 2010; 42: 547-54.